Moreover, ovarian cancer has the highest overall expression of BRD4 across all TCGA cancer types and patients with increased expression of BRD4 experienced significantly reduced survival times as determined through Kaplan–Meier analysis (Fig. 1c, d)6,31–35. Here, BRD4 is linked to ovarian carcinoma.